T     Articles by natural health author Tony Isaacs    


Home Article Directory Healthy Recipes Natural Remedies  The TBYIL Supplement & Health Catalog Beating/Avoiding Cancer Pets/Animals  Humor Diets/Weight Loss Natural Living Anti-Aging/Longevity Inspiration Contact Us
Share on Facebook Tweet This!   AddThis Social Bookmark Button

How the FDA Turned a $10 Treatment into a $1500 Money-Maker for a Sanctioned Drug Company


by Tony Isaacs

(The Best Years in Life) What's a poor faltering drug company to do when it has been busted for misdeeds, its shareholders are up in arms and its former CEO has been fined, sent to jail and banned from the industry? In the case of KV Pharmaceutical, the answer was to get the FDA to give the company exclusive rights to a common generic drug for expectant mothers and raise the price from $10 per treatment to $1500 - a decision which has outraged doctors, US senators, and even the March of Dimes.

Last year, the FDA made an eyebrow-raising decision to give exclusive rights to the generic drug to KV Pharmaceutical after declaring the drug to be an "orphan drug". As a consequence, low-income mothers and their babies will be put in grave jeopardy and a huge financial burden will be created for the health insurance companies, private citizens, and government programs that have to pay for it

The drug, Hydroxyprogesterone caproate, is a synthetic form of progesterone known commonly as 17P and it has been used since 1956 to prevent premature births. It is administered as a weekly injection, which means that the price hike for KV’s new Makena drug could bring the total cost during a pregnancy to as much as $30,000.

Doctors say the $30,000 price tag will almost certainly deter low-income women from getting the drug, leading to more premature births. “That’s a huge increase for something that can’t be costing them that much to make”, stated Dr. Roger Snow, deputy medical director for Massachusetts’ Medicaid program. “For crying out loud, this is about making money!”

Dr. Arnold Cohen, an obstetrician at Albert Einstein Medical Center in Philadelphia, observed, “I’ve never seen anything as outrageous as this.”

The non-profit March of Dimes, which has received funding from KV Pharmaceutical and initially supported the company’s New Drug Application, sent a letter to KV “expressing our serious concern about the price of Makena.”

Two senators, Minnesota Democrat Amy Klobuchar and Ohio Democrat Sherrod Brown, want the U.S. Federal Trade Commission to investigate the price that KV Pharmaceuticals (KVA) is charging for its brand new Makena drug for high-risk pregnancies. The senators contend that, given that versions of the same drug have been available from compounding pharmacies for many years at a fraction of the cost, the drugmaker, they charge, is engaging in price gouging.

Senator Brown also sent a letter to KV Pharmaceutical asking the company to “immediately reconsider” its pricing. “I am deeply concerned that your company appears to be taking advantage of FDA approval at the expense of women, children and federal and state budgets,” Brown wrote. “By ratcheting up prices, fewer women will be able to afford the drug, increasing rates of preterm birth nationwide. This isn’t in the interest of children, new mothers, or taxpayers.”


Lung issues common with premature births can have lifelong repercussions with an increased propensity toward asthma, bronchitis, and pneumonia, among other early birth issues. In the long run, because of birth complications, the babies will need to be hospitalized for perhaps months, all at the expense of taxpayers.

The Orphan Drug Act is meant to encourage pharmaceutical companies to develop drugs for uncommon diseases and conditions. However 17P treatments were already developed and approved and were already in use for years for a condition that is far from uncommon.

Besides declaring the drug an orphan, the FDA also raised questions by awarding exclusive rights to a company it had previously fined and sanctioned heavily. Just this month, former KV CEO Mark Hermelin - whom the FDA had essentially banned from the industry last November - pled guilty to overseeing the sale of poorly manufactured and oversized morphine sulfate tablets and other drugs in 2007 and 2008. He was sentenced to serve 30 days in jail, pay $1 million in fines and forfeit $900,000 in earnings.

Hermelin's sentence comes on the heels of a long list of recalls and violations by KV Pharmaceutical and its subsidiary, Ethex. KV production was put on hold in 2009 in the United States after the FDA cited the company for selling unadulterated and unapproved drugs. In 2008, Ethex Corp suspended manufacturing and shipments for all products after several generic drug recalls due to mislabeled drugs.

In November KV shareholders filed suit for being misled. That same month, the company announced that it would be relying on on a NYSE financial distress exception in order to sell stocks and secure funding to help it stay afloat.

However, with help from the FDA the company has more than rebounded. Company stock rose 131% the day after the FDA announced awarding KV exclusive rights to 17P (which will be marketed under the trade name Makena). KV stock, which had been as low as 61 cents a share last year, ultimately reached a high of over $13.

The fine and the light jail sentence for Hermelin comes amid increased pressure from critics of the FDA and pharmaceutical companies to levy real criminal consequences against drug company executives, as opposed to simply fining the companies. Hermelin's fine may have been covered via stock sales by a “beneficial owner” relative. Records show that on the third of March, Arnold L. Hermilin sold 100,000 shares of KV stock at over $10 per share. Under federal securities law “Beneficial owner” is a term which can be used for a person who has the power to dispose of stock held in another name.

Not surprisingly, the backlash over the unconscionable price hike has been significant - so much that KV hired the public relations firm Golin Harris to handle the mess. Jennifer Forst from Golin Harris writes: “Ther-Rx Corporation [a subsidiary of KV] announced the list price of Makena at $1,500 per injection. A patient’s out-of-pocket costs (copay) for Makena will likely be substantially less than the list price and will vary based on her health insurance provider and her insurance benefit design.” In other words, insurance, which consumers and companies pay for via premiums and taxes, will have to pick up the whole tab.

Though the actions against Hermelin and past actions against KV may play well with the public, one has to wonder: On balance, did either KV Pharmaceutical or Hermelin really pay a price?

Fortunately for natural health-conscious consumers, there are natural progesterone products which are safe, effective and less costly than even the generic progesterone shots.

See also:

Scandal at the FDA: board members with drug maker ties voted to approve drug that's killing women

FDA Banning Food Makers from Telling the Truth about Non-GMO Foods


Sources included:


About the author

Tony Isaacs is a member of the National Health Federation and the American Botanical Council. He is a natural health advocate and researcher and the author of books and articles about natural health including "Cancer's Natural Enemy." Mr. Isaacs articles are featured at The Truth About Cancer, the Health Science Institute's Healthiertalk website, CureZone, the Crusador, Health Secrets, the Cancer Tutor, the Silver Bulletin, the New Zealand Journal of Natural Health, and several other venues. In addition, he hosts the Yahoo Oleandersoup Health group of over 3500 members and the CureZone Ask Tony Isaacs - Featuring Luella May forum. He is also the local moderator of the CureZone Cancer Alternatives forum. Tony and his partner Luella May host The Best Years in Life natural health website where their motto is "It's never too late or too early to begin living longer, healthier and happier lives."



Your website hosts Tony Isaacs and Luella May

Click here to visit our CureZone Health Forum: Ask Tony Isaacs: Featuring Luella May– Natural Health, Cancer, Longevity and Home & Herbal Remedies.


Misty & My Buddy the "found dogs" - Official Mascots of The Best Years in Life


Mountain Rose Herbs. A Herbs, Health & Harmony Com   

For the best in health information, subscribe to The Best Years in Life Newsletter featuring articles by Tony M. Isaacs

Sign Up Now

Subscribe to The Best Years in Life Oleandersoup Hesalth Forum - Free Subscription
Powered by health.groups.yahoo.com

The Krill Miracle™

The Krill Miracle™

Concentrated Omega 3, 6 & 9, Many Times More Powerful than Fish Oil

The Best Colloidal Silver on the Planet!




100% Organic MicroComplexed™ IntraCELL™ Level IV Technology ~ 415 Nutrients All-In-One, Perfect Whole Foods & Phyto Nutrition ~ Super Energizing ~ All Natural Defense The Most Scientifically Advanced, Clinically Proven, Health Promoting Organic Nutritional Supplement Available Today!

Available Now!
Click on the image for more information


Sutherlandia OPC

The ultimate immune booster and immune modulator from South Africa

OPC Plus

Supreme immune booster from the makers of Sutherlandia OPC with 100 mg of pure oleander

Advanced Colloidal Gold

Boosts memory, mood, focus, helps relieve joint pain and much more.

Gold Aloe Skin Care Bar

If you would like to donate to help us keep this web site active and growing, click on the button above.   Much thanks! - Tony & Luella

The Best Years in Life
P O Box 121 Cooper TX  75432  Phone: 903-886-2436  Fax: 903-829-3434  Email: Dquixote1217[at]gmail.com- (replace [at] with @)

Disclaimer: The information on this page and on this website has not been evaluated by the FDA.  We do not diagnose, treat, cure or prevent illness or disease - instead, we try to help people learn how to do so themselves.  Anyone who believes they have a serious medical condition or health issue should seek diagnoses from a qualified medical professional before making any decisions on how to best address their health. We do not sell or advocate drugs, nor do we make any claims that anything advocated or sold on this website is a drug.  Furthermore, anyone contemplating using any products or information on this website must accept such use as experimental and voluntary.  No claims are made regarding the therapeutic use of the products or information on this website and all products featured or sold on this website must be considered nutritional supplements only.